More Time in Range2, , day and night.

The MiniMed™ 780G system automatically  adjusts insulin delivery and corrects glucose levels every 5 minutes 24/7, requiring no finger pricks. 

0
%
Time in Range3
Real world data shows
0
%
Overnight Average

Time in Range4, 

MiniMed™ 780G system

MiniMed™ 780G system

Now available for children with diabetes ages 2 years old+ and women during pregnancy.

MiniMed™ 780G system

Considering an automated insulin pump system?

When choosing an insulin pump, make sure it meets your needs and delivers the best results. Key considerations should include:

  • Time in Range (TIR):
    The percentage of time your blood glucose levels are within the target range. Higher TIR reduces complications like eye damage (retinopathy), heart and kidney disease.5
  • Burden reduction:
    Achieve more while doing less. Your pump should help you to stay in range even when carb counting isn't exact.6

Learn more about
the MiniMed™ 780G System.

Learn more

References

  1. dQ&A US Patient Voice Q2 2025. p. 77. n=2152. Data on file. Abbott Diabetes Care, Inc.
  2. Choudhary P, et al. Diabetes Technol Ther 2024; 26 (Suppl. 3): S32-S37.
  3. Arrieta A, et al. Diabetes Obes Metab. 2022; doi: 10.1111/dom.14714. Mean 80% TIR is reached using the recommended optimal settings of 2 hours active insulin time and 100 mg/dL (5.5 mmol/L) as glucose target for at least 90% of the time.
  4. McVean, et al. Diabetes Obes Metab. 2026;28(3):2456-2460
  5. De Meulemeester J. The association of chronic complications with time in tight range and time in range in people with type 1 diabetes: a retrospective cross-sectional real-world study. Diabetologia. 2024;67(8):1527-1535. doi:10.1007/s00125-024-06171-y
  6. Petrovski G, et al. Diabetes Care 2023;46(3):544–550
  • * Adults, T1 and parents of children with T1 diabetes < 18 years were surveyed based on their experience with Guardian™ 4 sensor.
  • ** Compared to MDI + isCGM
  • ^ Refer to System User Guide - SmartGuard™ feature. Some user interaction required
  • ^^ A blood glucose (BG) reading is needed when entering SmartGuard™ feature. If glucose alerts and CGM readings do not match your symptoms, use a BG meter to make diabetes treatment decisions. Refer to System User Guide - SmartGuard™ feature. Some user interaction required.
  • # Due to inherent real-world study limitations, caution is advised when attempting to extrapolate these results to new patients. There could be significant differences. Overnight period: 12:00 AM- 6:00 AM [24:00 h – 06:00 h]. Number of users with ≥10 days of sensor glucose data
  • ∞ Reached using optimal settings. Optimal settings are glucose target at 100 mg/dL (5.5 mmol/L) and Active Insulin Time (AIT) at 2 hours and used >95% of the time
  • 1.dQ&A US Patient Voice Q2 2025. p. 77. n=2152. Data on file. Abbott Diabetes Care, Inc.
  • 2.Choudhary P, et al. Diabetes Technol Ther 2024; 26 (Suppl. 3): S32-S37.
  • 3.Arrieta A, et al. Diabetes Obes Metab. 2022; doi: 10.1111/dom.14714. Mean 80% TIR is reached using the recommended optimal settings of 2 hours active insulin time and 100 mg/dL (5.5 mmol/L) as glucose target for at least 90% of the time.
  • 4.McVean, et al. Diabetes Obes Metab. 2026;28(3):2456-2460
  • 5.De Meulemeester J. The association of chronic complications with time in tight range and time in range in people with type 1 diabetes: a retrospective cross-sectional real-world study. Diabetologia. 2024;67(8):1527-1535. doi:10.1007/s00125-024-06171-y
  • 6.Petrovski G, et al. Diabetes Care 2023;46(3):544–550
  • * Adults, T1 and parents of children with T1 diabetes < 18 years were surveyed based on their experience with Guardian™ 4 sensor.
  • ** Compared to MDI + isCGM
  • ^ Refer to System User Guide - SmartGuard™ feature. Some user interaction required
  • ^^ A blood glucose (BG) reading is needed when entering SmartGuard™ feature. If glucose alerts and CGM readings do not match your symptoms, use a BG meter to make diabetes treatment decisions. Refer to System User Guide - SmartGuard™ feature. Some user interaction required.
  • # Due to inherent real-world study limitations, caution is advised when attempting to extrapolate these results to new patients. There could be significant differences. Overnight period: 12:00 AM- 6:00 AM [24:00 h – 06:00 h]. Number of users with ≥10 days of sensor glucose data
  • ∞ Reached using optimal settings. Optimal settings are glucose target at 100 mg/dL (5.5 mmol/L) and Active Insulin Time (AIT) at 2 hours and used >95% of the time
  • ^ Refer to System User Guide - SmartGuard™ feature. Some user interaction required
  • ^^ A blood glucose (BG) reading is needed when entering SmartGuard™ feature. If glucose alerts and CGM readings do not match your symptoms, use a BG meter to make diabetes treatment decisions. Refer to System User Guide - SmartGuard™ feature. Some user interaction required.
  • # Due to inherent real-world study limitations, caution is advised when attempting to extrapolate these results to new patients. There could be significant differences. Overnight period: 12:00 AM- 6:00 AM [24:00 h – 06:00 h]. Number of users with ≥10 days of sensor glucose data
  • ∞ Reached using optimal settings. Optimal settings are glucose target at 100 mg/dL (5.5 mmol/L) and Active Insulin Time (AIT) at 2 hours and used >95% of the time

CE-DBA-2600170© 2026 MiniMed. MiniMed and MiniMed logo are trademarks of MiniMed, Inc.

The sensor shape and appearance, Abbott and “a” logo are marks and/or designs of the Abbott group of companies in various territories and used under licence. Sensor image © 2026 Abbott.

*Third–party brands are trademarks of their respective owners.